Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $604.25 | 35 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $98.15 | 5 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $78.82 | 6 | $0 (2019) |
| Allergan Inc. | $62.19 | 4 | $0 (2017) |
| Amarin Pharma Inc. | $58.25 | 3 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $41.39 | 2 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $38.79 | 2 | $0 (2017) |
| Amgen Inc. | $37.28 | 2 | $0 (2017) |
| Teva Pharmaceuticals USA, Inc. | $28.54 | 2 | $0 (2017) |
| Boston Scientific Corporation | $28.39 | 1 | $0 (2019) |
| Abbott Laboratories | $20.70 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $77.25 | 4 | Boston Scientific Corporation ($28.39) |
| 2018 | $62.21 | 3 | GlaxoSmithKline, LLC. ($41.51) |
| 2017 | $464.79 | 28 | Allergan Inc. ($62.19) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2019 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: VACCINE | ||||||
| 05/30/2019 | Merck Sharp & Dohme Corporation | GARDASIL9 (Biological) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: VACCINE | ||||||
| 05/15/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological), MENVEO, SHINGRIX | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: VACCINES | ||||||
| 03/20/2019 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: STRUCTURAL HEART | ||||||
| 09/28/2018 | Abbott Laboratories | FreeStyle Libre blood glucose Flash Monitoring System (Device) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Diabetes Care | ||||||
| 05/23/2018 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: VACCINES | ||||||
| 02/21/2018 | GlaxoSmithKline, LLC. | BEXSERO (Biological), MENVEO | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: VACCINES | ||||||
| 11/08/2017 | GlaxoSmithKline, LLC. | FLUARIX (Biological), BOOSTRIX, ENGERIX-B | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: VACCINES | ||||||
| 07/27/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Respiratory | ||||||
| 07/20/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/28/2017 | Teva Pharmaceuticals USA, Inc. | QVAR (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Respiratory | ||||||
| 06/28/2017 | Teva Pharmaceuticals USA, Inc. | QVAR (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Respiratory | ||||||
| 06/28/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/21/2017 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/15/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Endocrinology | ||||||
| 06/14/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Hypertriglyceridemia | ||||||
| 06/08/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: NEUROSCIENCE | ||||||
| 06/02/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: RESPIRATORY | ||||||
| 05/24/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Urology | ||||||
| 05/22/2017 | Antares Pharma, Inc. | Otrexup (methotrexate) injection (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Rheumatoid Arthritis | ||||||
| 04/19/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Diabetes | ||||||
| 04/19/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ZOSTAVAX | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/06/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2017 | Merck Sharp & Dohme Corporation | ZOSTAVAX (Biological), PNEUMOVAX 23, GARDASIL9 | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: VACCINE | ||||||
| 03/29/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 243 | 351 | $75,705 | $30,915 |
| 2022 | 6 | 261 | 331 | $64,860 | $26,978 |
| 2021 | 7 | 317 | 381 | $72,800 | $32,424 |
| 2020 | 9 | 280 | 338 | $59,279 | $22,379 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 194 | $45,590 | $16,394 | 36.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 45 | 45 | $10,800 | $6,021 | 55.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $8,415 | $3,361 | 39.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 32 | 32 | $5,760 | $2,420 | 42.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 22 | $3,410 | $1,244 | 36.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 34 | $1,190 | $1,090 | 91.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $540.00 | $384.60 | 71.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 150 | $35,250 | $12,241 | 34.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 51 | 51 | $12,240 | $7,034 | 57.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 39 | 42 | $6,720 | $2,939 | 43.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 11 | 11 | $4,235 | $1,942 | 45.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 43 | 46 | $1,610 | $1,447 | 89.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 31 | $4,805 | $1,374 | 28.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 93 | 139 | $32,015 | $12,442 | 38.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 58 | 58 | $13,920 | $8,322 | 59.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 50 | $7,600 | $3,357 | 44.2% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 46 | 47 | $7,520 | $3,050 | 40.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 14 | 14 | $5,390 | $2,538 | 47.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 18 | 20 | $4,500 | $1,769 | 39.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 52 | 53 | $1,855 | $945.96 | 51.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 79 | 110 | $24,009 | $7,444 | 31.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 32 | 32 | $7,680 | $4,027 | 52.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 36 | 58 | $8,700 | $2,968 | 34.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 12 | 12 | $4,570 | $2,220 | 48.6% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2020 | 32 | 32 | $5,120 | $1,952 | 38.1% |
About Dr. Tamara Fedec, D.O
Dr. Tamara Fedec, D.O is a Family Medicine healthcare provider based in Bala Cynwyd, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124085725.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tamara Fedec, D.O has received a total of $604.25 in payments from pharmaceutical and medical device companies, with $77.25 received in 2019. These payments were reported across 35 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($604.25).
As a Medicare-enrolled provider, Fedec has provided services to 1,101 Medicare beneficiaries, totaling 1,401 services with total Medicare billing of $112,697. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Bala Cynwyd, PA
- Active Since 04/27/2006
- Last Updated 09/16/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1124085725
Products in Payments
- Vascepa (Drug) $58.25
- NAMZARIC (Drug) $50.76
- BEXSERO (Biological) $43.94
- PRALUENT (Drug) $41.39
- ENTRESTO (Drug) $38.79
- JANUVIA (Drug) $37.99
- Prolia (Biological) $37.28
- QVAR (Drug) $28.54
- WATCHMAN (Device) $28.39
- FreeStyle Libre blood glucose Flash Monitoring System (Device) $20.70
- SHINGRIX (Biological) $19.43
- Mitigare (Drug) $19.08
- Otrexup (methotrexate) injection (Drug) $18.71
- FLUARIX (Biological) $18.67
- TRULICITY (Drug) $16.90
- ANORO (Drug) $16.11
- Myrbetriq (Drug) $15.54
- PNEUMOVAX 23 (Biological) $15.05
- SPIRIVA (Drug) $14.85
- ZOSTAVAX (Biological) $13.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bala Cynwyd
Dr. Yuliya Gombar, D.o, D.O
Family Medicine — Payments: $4,074
Dr. Andrew Kirschner, D.o, D.O
Family Medicine — Payments: $2,184
Leslie Partem, Md, MD
Family Medicine — Payments: $709.27
Megan Jones, D.o, D.O
Family Medicine — Payments: $621.81
Dr. Richard Watson, D.o, D.O
Family Medicine — Payments: $619.57
Dr. Ali Kadkhoda, Do, DO
Family Medicine — Payments: $416.12